Cargando…
The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy
BACKGROUND: This study aimed to preliminarily assess the relationship between erythropoietin‐producing hepatocellular carcinoma receptor A3 (EphA3) and androgen receptor (AR) protein expression levels and prognosis in prostate cancer (PCa) to better understand the role of EphA3 in the prognosis and...
Autores principales: | Duan, Xiuzhi, Xu, Xiaoming, Yin, Binbin, Hong, Bong, Liu, Weiwei, Liu, Qian, Tao, Zhihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595293/ https://www.ncbi.nlm.nih.gov/pubmed/30958616 http://dx.doi.org/10.1002/jcla.22871 |
Ejemplares similares
-
EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016) -
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020) -
Downregulation of EphA5 by promoter methylation in human prostate cancer
por: Li, Shibao, et al.
Publicado: (2015) -
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004) -
EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression
por: Li, Shibao, et al.
Publicado: (2015)